BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27537550)

  • 1. Incongruent reduction of dopamine transporter availability in different subgroups of alcohol dependence.
    Yen CH; Shih MC; Cheng CY; Ma KH; Lu RB; Huang SY
    Medicine (Baltimore); 2016 Aug; 95(33):e4048. PubMed ID: 27537550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Dopamine Transporter Availability and Neurocognitive Deficits in Male Patients with Alcohol Dependence.
    Yen CH; Yeh YW; Liang CS; Ho PS; Kuo SC; Huang CC; Chen CY; Shih MC; Ma KH; Peng GS; Lu RB; Huang SY
    PLoS One; 2015; 10(6):e0131017. PubMed ID: 26120847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced striatal dopamine transporter density associated with working memory deficits in opioid-dependent male subjects: a SPECT study.
    Liang CS; Ho PS; Yen CH; Yeh YW; Kuo SC; Huang CC; Chen CY; Shih MC; Ma KH; Huang SY
    Addict Biol; 2016 Jan; 21(1):196-204. PubMed ID: 25439653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between errors on the Wisconsin Card Sorting Test and the availability of striatal dopamine transporters in healthy volunteers.
    Hsieh PC; Yeh TL; Lee IH; Huang HC; Chen PS; Yang YK; Chiu NT; Lu RB; Liao MH
    J Psychiatry Neurosci; 2010 Mar; 35(2):90-4. PubMed ID: 20184806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of depressive symptoms and peripheral DAT methylation on neural reactivity to alcohol cues in alcoholism.
    Wiers CE; Shumay E; Volkow ND; Frieling H; Kotsiari A; Lindenmeyer J; Walter H; Bermpohl F
    Transl Psychiatry; 2015 Sep; 5(9):e648. PubMed ID: 26418276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine transporter availability in alcohol and opioid dependent subjects - a
    Grover T; Gupta R; Arora G; Bal CS; Ambekar A; Basu Ray S; Vaswani M; Sharma A
    Psychiatry Res Neuroimaging; 2020 Nov; 305():111187. PubMed ID: 32947183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients.
    Zaaijer ER; van Dijk L; de Bruin K; Goudriaan AE; Lammers LA; Koeter MW; van den Brink W; Booij J
    Psychopharmacology (Berl); 2015 Jul; 232(14):2597-607. PubMed ID: 25757673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal changes in the dopamine transporter and cognition in suicide attempters with charcoal burning.
    Yang KC; Wang SJ; Hsieh WC; Lirng JF; Yang CC; Deng JF; Lin CL; Chou YH
    Psychiatry Res; 2015 Feb; 231(2):160-7. PubMed ID: 25572798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between the striatal dopamine transporter and novelty seeking and cognitive flexibility in opioid dependence.
    Liang CS; Ho PS; Yen CH; Chen CY; Kuo SC; Huang CC; Yeh YW; Ma KH; Huang SY
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Mar; 74():36-42. PubMed ID: 27940252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic imaging study with [Tc-
    Akay AP; Kaya GÇ; Kose S; Yazıcıoğlu ÇE; Erkuran HÖ; Güney SA; Oğuz K; Keskin D; Baykara B; Emiroğlu Nİ; Eren MŞ; Kızıldağ S; Ertay T; Özsoylu D; Miral S; Durak H; Gönül AS; Rohde LA
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():294-300. PubMed ID: 29684537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of dopamine transporter and metabolite ratios underpinning the cognitive dysfunction in patients with carbon monoxide poisoning: A combined SPECT and MRS study.
    Yang KC; Yang BH; Lirng JF; Liu MN; Hu LY; Liou YJ; Chan LA; Chou YH
    Neurotoxicology; 2021 Jan; 82():26-34. PubMed ID: 33171150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine transporter availability and depressive symptoms during alcohol withdrawal.
    Laine TP; Ahonen A; Räsänen P; Tiihonen J
    Psychiatry Res; 1999 Jun; 90(3):153-7. PubMed ID: 10466734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.
    Crunelle CL; van den Brink W; Veltman DJ; van Emmerik-van Oortmerssen K; Dom G; Schoevers RA; Booij J
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1714-23. PubMed ID: 23731497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution volume ratio of serotonin and dopamine transporters in euthymic patients with a history of major depression - a dual-isotope SPECT study.
    Hsieh PC; Lee IH; Yeh TL; Chen KC; Huang HC; Chen PS; Yang YK; Yao WJ; Lu RB; Chiu NT
    Psychiatry Res; 2010 Dec; 184(3):157-61. PubMed ID: 21030217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease.
    Weintraub D; Newberg AB; Cary MS; Siderowf AD; Moberg PJ; Kleiner-Fisman G; Duda JE; Stern MB; Mozley D; Katz IR
    J Nucl Med; 2005 Feb; 46(2):227-32. PubMed ID: 15695780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No changes in striatal dopamine transporter in antidepressant-treated patients with major depression.
    Wu CK; Chin Chen K; See Chen P; Chiu NT; Yeh TL; Lee IH; Yang YK
    Int Clin Psychopharmacol; 2013 May; 28(3):141-4. PubMed ID: 23524636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction between dopamine transporter function, gender differences, and possible laterality in depression.
    Hsiao MC; Lin KJ; Liu CY; Schatz DB
    Psychiatry Res; 2013 Jan; 211(1):72-7. PubMed ID: 23036826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine transporter availability in heroin-dependent subjects and controls: longitudinal changes during abstinence and the effects of Jitai tablets treatment.
    Liu Y; Han M; Liu X; Deng Y; Li Y; Yuan J; Lv R; Wang Y; Zhang G; Gao J
    Psychopharmacology (Berl); 2013 Nov; 230(2):235-44. PubMed ID: 23715641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine transporter density may be associated with the depressed affect in healthy subjects.
    Newberg A; Amsterdam J; Shults J
    Nucl Med Commun; 2007 Jan; 28(1):3-6. PubMed ID: 17159542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired brain dopamine transporter in chemobrain patients submitted to brain SPECT imaging using the technetium-99m labeled tracer TRODAT-1.
    Vitor T; Kozasa EH; Bressan RA; Lacerda SS; Campos Neto GC; Batista IR; Gebrim LH; Cohen L; Amaro E; Felicio AC
    Ann Nucl Med; 2019 Apr; 33(4):269-279. PubMed ID: 30843155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.